Plasma BNP appears to be cardioprotective by increasing cyclic GMP levels and activating G kinase10, but it also increases with worsening HF18; these facts provide evidence that increases in the BNP levels may precisely predict the occurrence of cardiovascular events in patients with HF. This evidence concerns the gene NPPB and hydrops fetalis.